Search Within

William K Kelly

  1. "Breast Medicine Service"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (4)
  3. Conference Paper (1)
Groups
  1. Breast Medicine Service (9)
  2. Department of Medicine (9)
  3. Genitourinary Oncology Service (9)
  4. Solid Tumor Oncology Division (9)
  5. GSK Faculty (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Howard Scher (9)
  2. Neal Rosen (8)
  3. Susan Slovin (8)
  4. Michael Morris (7)
  5. Carlos Cordon-Cardo (4)
  6. David Solit (3)

More People

Years
  1. 2007 (1)
  2. 2006 (1)
  3. 2005 (3)
  4. 2002 (1)
  5. 2001 (1)
  6. 1999 (1)

More Years

Publications
  1. Clinical Cancer Research (4)
  2. Applied Immunohistochemistry & Molecular Morphology (1)
  3. EJC Supplements (1)
  4. European Journal of Cancer (1)
  5. Journal of Clinical Oncology (1)
  6. Seminars in Oncology (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Elsevier Inc. (2)
  3. American Society of Clinical Oncology (1)
  4. Lippincott Williams & Wilkins (1)
  5. Pergamon-Elsevier Science Ltd (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer
    Journal Article

    Solit, D. B.; Ivy, S. P.; Kopil, C.; Sikorski, R.; Morris, M. J.; Slovin, S. F.; Kelly, W. K.; Delacruz, A.; Curley, T.; Heller, G.; more...
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Pharmacokinetics and toxicity of weekly docetaxel in older patients
    Journal Article

    Hurria, A.; Fleming, M. T.; Baker, S. D.; Kelly, Wm K.; Cutchall, K.; Panageas, K.; Caravelli, J.; Yeung, H.; Kris, M. G.; Gomez, J.; more...
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer
    Journal Article

    Morris, M. J.; Cordon-Cardo, C.; Kelly, W. K.; Slovin, S. F.; Siedlecki, K.; Regan, K. P.; DiPaola, R. S.; Rafi, M.; Rosen, N.; Scher, H. I.
    Applied Immunohistochemistry & Molecular Morphology (2005)

    Fulltext@MSK | Save
  • Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer
    Journal Article

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; Siedlecki, K.; Swanson, P.; Rafi, M.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • BCL-2 antisense (G3139) plus docetaxel for treatment of progressive androgen-independent prostate cancer
    Meeting Abstract

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Rosen, N.; Scher, H. I.
    European Journal of Cancer (2001)

    Fulltext@MSK | Save
  • A phase I trial of BCL2 antisense drug G3139 (Genta, Inc.) delivered by continuous intravenous infusion alone and in combination with weekly paclitaxel
    Meeting Abstract

    Morris, M. J.; Tong, W. P.; Cordon-Cardo, C.; Drobnjak, M.; Kelly, W. K.; Slovin, S. F.; Terry, K. L.; DiPaola, R. S.; Rosen, N.; Scher, H. I.
    Clinical Cancer Research (1999)

    Fulltext@MSK | Save
  • Targeted therapy for prostate cancer: The Memorial Sloan-Kettering Cancer Center approach
    Conference Paper

    Slovin, S. F.; Livingston, P. O.; Rosen, N.; Sepp-Lorenzino, L.; Kelly, W. K.; Mendelsohn, J.; Scher, H. I.
    Elsevier Inc. (1996)

    Fulltext@MSK | Save